IGF-1 LR3

Overview

IGF-1 LR3 (Insulin-Like Growth Factor 1 Long Arg3) is a synthetic research peptide that is a modified version of human IGF-1 with an extended half-life and enhanced bioactivity. In laboratory settings, IGF-1 LR3 is studied for its potential effects on cellular growth, protein synthesis, and muscle development in test models such as laboratory rodents.

Benefits

Preclinical studies suggest that IGF-1 LR3 may promote increased cell growth, improved protein synthesis, and enhanced muscle tissue development in research animals. Its extended half-life compared to standard IGF-1 allows for prolonged activity in laboratory studies, supporting research into tissue growth and regeneration pathways.
Source: Donaghy A. Effects of IGF-1 and its analogues on muscle growth and metabolism. Journal of Endocrinology, 2000. Link

Possible Side Effects

Research involving IGF-1 LR3 has shown that test subjects may experience mild hypoglycemia-like responses, water retention, or injection site irritation. Dosage and frequency should be carefully managed to avoid undesired responses in laboratory settings.
Source: Donaghy A., Journal of Endocrinology, 2000.

Dosage & Administration

IGF-1 LR3 is typically administered via subcutaneous injection under controlled research protocols. Common research dosages range from 20 mcg to 120 mcg per day, depending on the study design, species used, and desired research endpoints. Frequency is generally daily or multiple times per week for short study periods.
For laboratory research use only. Not for human consumption.

Summary

IGF-1 LR3 is an extended half-life analog of IGF-1 designed exclusively for laboratory research exploring cell growth, protein synthesis, and muscle development in preclinical models. Research indicates potential for enhanced muscle tissue support and improved anabolic activity, with mild side effects such as low glucose markers and localized reactions reported in test subjects. IGF-1 LR3 is administered by subcutaneous injection under strict laboratory protocols, with dosage tailored to each study.
Strictly for research purposes only. Not for human use.